1. ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
    Yaolu Wei et al, 2022, Frontiers in Oncology CrossRef
  2. MicroRNA Expression Signatures in Clear Cell Renal Cell Carcinoma: High-Throughput Searching for Key miRNA Markers in Patients from the Volga-Ural Region of Eurasian Continent
    Irina Gilyazova et al, 2023, International Journal of Molecular Sciences CrossRef
  3. CircPRDM2 Contributes to Doxorubicin Resistance of Osteosarcoma by Elevating EZH2 via Sponging miR-760
    Jianjun Yuan et al, 2021, Cancer Management and Research CrossRef
  4. chi-miR-487b-3p Inhibits Goat Myoblast Proliferation and Differentiation by Targeting IRS1 through the IRS1/PI3K/Akt Signaling Pathway
    Ming Lyu et al, 2021, International Journal of Molecular Sciences CrossRef
  5. An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology
    Marcella Massimini et al, 2021, Frontiers in Veterinary Science CrossRef
  6. MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity
    Negin Soghli et al, 2022, Biochemical Pharmacology CrossRef
  7. Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters
    Sara R. Martins-Neves et al, 2022, International Journal of Molecular Sciences CrossRef
  8. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA
    Hefen Chen et al, 2024, Drug Development Research CrossRef
  9. Stem Cells: Therapeutic Implications in Chemotherapy and Radiotherapy Resistance in Cancer Therapy
    Tejaswini Patil et al, 2023, Current Stem Cell Research & Therapy CrossRef
  10. The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and Beyond
    Meghan E. McLean et al, 2023, Cancers CrossRef
  11. Analysis of microRNA expression in CD133 positive cancer stem‑like cells of human osteosarcoma cell line MG-63
    Xiong Shu et al, 2021, PeerJ CrossRef